Navigation Links
Respect Life and the Truth on Respect Life Sunday
Date:10/3/2009

WASHINGTON, Oct. 3 /PRNewswire-USNewswire/ -- Jon O'Brien, president of Catholics for Choice, issued the following statement on Respect Life Sunday:

"This Sunday, the United States Conference of Catholic Bishops holds its annual Respect Life Sunday. On this occasion, we would like to encourage the US bishops to also respect the truth. A recent publication by the USCCB, a brochure entitled Contraception: The Fine Print, and recent polls on healthcare reform prove that the bishops' desire to promote their own views on reproductive health leads them to play fast and loose with the truth.

"The erroneous claims in the brochure are too many to name, however, a few of the more egregious errors are worth mentioning. Having failed to convince Catholics that using contraception is wrong (97 percent of sexually active Catholic women use a method of contraception banned by the hierarchy), the brochure uses the all-too-common tactic of fear-mongering to drive the bishops' message. It states that contraception contributes to unintended pregnancies and new cases of sexually transmitted infections, when scientific, peer-reviewed studies have found contraception to do quite the opposite. On HIV prevention alone, the Centers for Disease Control marks condom use as a cornerstone of prevention, noting that condom use--while not 100 percent effective--can go a long way to prevent the transmission of STIs.

"Instead of using contraception, the brochure suggests only natural family planning for married couples and abstinence for single people. While we believe that people who choose these options should be able to do so freely and that they can work for some, we also recognize that abstinence and NFP don't suit everybody. On top of that, NFP does not have nearly as good of a track record as the brochure claims. According to a study by the Guttmacher Institute, even those who use NFP perfectly experience a nine percent failure rate, 8.7 percent mor
'/>"/>

SOURCE Catholics for Choice
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
2. Profarmas Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively
3. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
4. Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
5. Grupo Casa Saba Announces Sales and Operating Income Increased 14.05% and 13.45%, Respectively
6. VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment
7. THCA: Protecting Seniors, Respecting Taxpayers the Right Agenda for Texas
8. Classified -- the lonely hearts long road to respectability
9. Americas #1 Companion Gets Respect: The CATalyst 2009 Top 10 Cat-Friendly Cities
10. Dr.Khanna Featured in Highly Respected Trade Journal
11. Respected Surgeon Receives Emmy Nomination

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , "This bill provides for an unprecedente...health care about if it is not for preserving and ... it must be defeated." Charmaine Yoest ,, WA...cans United for Life Action President and CEO Dr. ... Senate by releasing the following statement: ,...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire...o eliminate onchocerciasis (river blindness) in th...e of the disease in recent years, as evidenced by ...ing mass drug administration in six endemic countr...al meeting of the American Society of Tropical Med...
(Date:11/21/2009)..., LONDON, November 21, 2009 /PRNewswire-Fir... Test Test Test Test Test Test Test Test Test Test... Test Test Test Test Test Test,Test Test Test Test... More test More test More test More test More tes...t More test More test More test More test More,tes...
(Date:11/21/2009)... Innovative medical apparel co...erence , San Clemente, Ca...aker of breakthrough medical apparel, today announ...n display at Medica 2009, a leading international ...dorf, Germany. Medelita inaugurates its men,s coll...
(Date:11/21/2009)... Eric J. Hall, president and c...on of America (AFA) issued the following statement...etection as part of the new annual wellness for Me...on and Affordable Care Act" that was introduc..., NY (PRWEB) November 21, 2009 -- Eric J. Hall, pr...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3
...t Listed on Product Labels Due to Weak Regulatory ...ting claims like "gentle" and "pure," dozens of to...d with the cancer-causing chemicals formaldehyde a...abels because contaminants are exempt from labelin...
...March 12 For the past three decades, employers ha...e costs. Now some are pinning their hopes on a rel..., which link high-deductible health insurance plan...ent in Health Care -- 30 Years into the Experiment...
...perts in cancer and nutrition are meeting in Zuric...edge research in one of the most important and fie...k between diet and cancer. , There is growing ev...so have a negative impact on cancer management and...
...- The long tails sported by many male birds in the...and a distinct disadvantage when fleeing predators...keley, biologists shows that they exact only a min...cent, which means the bird has to visit 1 to 3 per...
...ass., March 12 North American application activit... up +1.1% in February, year-over-year, according t...from January to February 2009 was up +12.9%. Year...butable to the Life Index methodology rather than ...
...Partners Offer Consumers Chance to Win Tickets to ...RSIPPANY, N.J., March 12 alli announced today a s...ity to attend a private Wynonna Judd concert in Na...nd,s spokesperson, in an intimate setting while sh...
Other Medicine News:Health News:Children's Bath Products Contaminated With Formaldehyde, 1,4-Dioxane 2Health News:Children's Bath Products Contaminated With Formaldehyde, 1,4-Dioxane 3Health News:EBRI Policy Forum: Consumer/Patient Engagement in Health Care - 30 Years On 2Health News:New data on link between cancer and nutrition discussed at European symposium 2Health News:Long, sexy tails not a drag on male birds 2Health News:Long, sexy tails not a drag on male birds 3Health News:Long, sexy tails not a drag on male birds 4Health News:MIB Life Index Reports North American Life Insurance Activity up 1.1% in February 2Health News:MIB Life Index Reports North American Life Insurance Activity up 1.1% in February 3Health News:Wynonna Judd and alli Host Private Concert in Nashville 2
(Date:11/20/2009)...ov. 20 Soligenix, Inc. (...y), formerly known as DOR BioPharma, Inc., a late-...it has formed a consortium to develop thermostable... acting vaccines. Soligenix received a $9.4 millio... Infectious Diseases (NIAID), a division of the Na...
(Date:11/19/2009)...Nov. 19 BioCryst Pharmac...e pricing of a public offering of 5,000,000 shares... in gross proceeds of $48.75 million. All of the ...n effective shelf registration statement previousl...n. BioCryst has also granted the underwriters a 3...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3OPAXIO 28TM 29 Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annu 5050 1Open innovation networks are one key to improved care 58222 1Open innovation networks are one key to improved care 58222 2Open innovation networks are one key to improved care 58222 3Open innovation networks are one key to improved care 58222 4Open innovation networks are one key to improved care 58222 5Fish fend off invading germs with an initial response similar to the one found in people 10082 1Fish fend off invading germs with an initial response similar to the one found in people 10082 2
... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), ...oday announced that it will present updated result...one-year survival data, during a,poster discussion...Study of,Lung Cancer,s (IASLC) 12th World Conferen... Poster number: PD6-1-1 Title: A phase 2 study o...
... (Nasdaq:,VICL) announced today that results from ...using a plasmid DNA (pDNA) vaccine developed by th...Vical, reinforced previously,reported Phase 1 conc...,vaccine regimen was safe and well-tolerated, and ...in up to 70% of the vaccine recipients. "These re...
Other Medicine Technology:Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 2Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3
Ocular Three Mirror 10 mm Gonio
Ocular Magna View Gonio
Ocular Koeppe Diagnostic
Mcintyre Cannula
Medicine Products: